UNSPSC 51284142: Ceftazidime sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C22H21N6O7S2.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CMC30V039K. The term ceftazidime sodium is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule ceftazidime sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFTAZIDIME SODIUM remains US FDA's Preferred Term for this commodity. Ceftazidime sodium bears US NLM identifiers UMLS ID C0700860 and NCI Concept Code C355.

SMILES: CC(C)(C(=O)[O-])O/N=C(/C1CSC(N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4CCCCC4)C(=O)[O-].[NA+].

UNSPSC 51284142 Ceftazidime sodium is a Commodity code that nominally designates a specific antibiotic pharmaceutical, but recent state and local solicitations tagged with this code do not reflect procurement of ceftazidime itself. Instead, the opportunities show that issuing bodies are using this code to solicit broader pharmaceutical, medical supply, and pharmacy benefit program services—including naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription programs. The actual buying activity spans emergency medical supplies for fire departments and community health programs, generic drugs distributed through cooperative purchasing alliances, and exploratory procurement for pharmacy benefit innovation. This divergence suggests the code is being applied loosely to pharmaceutical-adjacent procurements rather than to ceftazidime sodium specifically.

The issuing-body mix includes county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), state health agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities). Recent activity appears concentrated in Florida, Texas, and Minnesota, with cooperative purchasing vehicles playing a significant role in aggregating demand across multiple jurisdictions. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (1,900 and 800 units annually, due July 26, 2023), the City of Tampa's bid for medical and first aid supplies to the Fire Department Rescue Division ($700,000 estimated, due March 13, 2026, designated for certified Small Local Business Enterprises with a 5% bid discount), the Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026, effective July 1, 2026), and the Texas HHS Commission RFI for direct-to-manufacturer prescription programs (posted April 3, 2026). The code shows modest recent activity with a clear mismatch between its nominal scope and the work actually being solicited.